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INTRODUCTION
The development of minimally invasive techniques for cardiac surgery began to take shape in the mid-1990s, as surgeons explored the potential of these techniques to decrease cardiopulmonary perfusion times, incision size, wound infection and other complications [1, 2] . Since the first demonstration of the relative safety of minimally invasive approaches in mitral valve surgery, the variety of instruments, devices and perfusion techniques has continued to grow [3] . Today, these approaches are increasingly preferred over median sternotomy approaches [4] [5] [6] . At the same time, there has been concern that minimally invasive approaches with retrograde femoral perfusion may be associated with a higher risk of stroke/ transient ischaemic attack (TIA) than median sternotomy techniques, especially in patients with significant peripheral vascular disease [4, 7, 8] . Moreover, there is a notion that performing minimally invasive mitral valve surgery on a fibrillating heart may be associated with an increased risk for morbidity and, especially, strokes, although reports from experienced centres may contradict this point [9] . In this study, we examined whether the risk of stroke/TIA with minimally invasive mitral valve surgery with fibrillatory arrest and femoral cannulation is higher than that with median sternotomy and cardioplegic arrest.
MATERIALS AND METHODS
All patients who underwent first-time isolated mitral valve surgery between 2008 and 2014 at our centre were eligible for the present analyses (n = 387). Data were collected prospectively on 239 patients who underwent minimally invasive surgery and 148 patients who had median sternotomy surgery. All of the minimally invasive mitral valve surgeries in this sample were performed through a right minithoracotomy (5-6 cm) on a fibrillating heart with no aortic cross-clamping. This study primarily utilized data collected prospectively from our local Society of Thoracic Surgeons (STS) database and from supplemental data collected prospectively in our institutional cardiac surgery database. The primary outcomes for this study included perioperative stroke/ TIA, other major morbidity and operative mortality (<30 days). All outcomes were captured according to STS definitions. Stroke was defined as 'any confirmed neurological deficit of abrupt onset caused by a disturbance in blood supply to the brain that did not resolve within 24 h'. TIA was defined as 'loss of neurological function that was abrupt in onset, but with complete return of function within 24 h'. Criteria for the major morbidity composite outcome were one or more of the following: perioperative myocardial infarction, wound infection, pneumonia, reoperation for bleeding, perioperative renal failure or operative mortality (<30 days).
Preoperative screening
All patients underwent cardiac catheterization to rule out coronary artery disease. Computed tomography (CT) angiography of the chest, abdomen and lower extremities was performed to identify significant aortic or peripheral atheromatous disease that would preclude femoral cannulation and retrograde perfusion.
Operative technique
All minimally invasive procedures were performed by surgeons who were experienced in minimally invasive mitral valve surgery. The minimally invasive mitral valve technique was performed on the fibrillating heart as described previously [10] . Briefly, the left femoral artery and vein were exposed and cannulated. A right anterolateral minithoracotomy (5-6 cm) was made and the right chest entered through the fourth intercostal space. The pericardium was opened 2 cm anterior to the right phrenic nerve. Ventricular fibrillation was electrically induced, and a left atriotomy incision was performed. Mitral valve repair or replacement was performed under direct vision with standard minimally invasive tools. Conversion to cross-clamp and cardioplegia or conversion to sternotomy was not required in this sample. Upon completion of the open-heart procedure, the lungs were insufflated and extensive air evacuation manoeuvres were performed. The patient was rewarmed, defibrillated with external pads (Medtronic, Minneapolis, MN, USA) and weaned off cardiopulmonary bypass. The arterial and venous cannulae were removed, and the vessels repaired. The groin incision was closed, a Blake drain was placed in the right pleural chest and the thoracotomy was closed.
Statistical analysis
All analyses were conducted with SPSS Version 17.0 (SPSS, Inc., Chicago, IL, USA) and R 2.10.1 (The R Foundation for Statistical Computing; Vienna, Austria). For all analyses, a two-sided P of <0.05 was used to determine significance. Continuous data are presented as mean ± standard deviation, and categorical data are presented as frequency (percent) unless otherwise noted. Analyses comparing patient characteristics by operative approach included Student's independent-sample t-tests and Mann-Whitney U-tests for continuous variables and χ 2 tests for categorical variables. The effect of operative approach on stroke/TIA and major morbidity was examined for the full sample with univariate and multivariate analyses. Univariate analyses were conducted with χ 2 tests, and multivariate analyses were conducted with logistic regressions adjusted for age and STS-predicted risk. The multivariate analysis for stroke/TIA was adjusted for age and STS-predicted risk for stroke, whereas the multivariate analysis for major morbidity was adjusted for STS-predicted risk for morbidity/mortality.
Propensity score matching (PSM) was conducted with the MatchIt package for R to improve covariate balance across the operative approach groups. The propensity score was estimated with a logistic model, using the following covariates: age, gender, ejection fraction, peripheral vascular disease, chronic pulmonary disease, prior cerebrovascular accident, history of atrial fibrillation or atrial flutter, mitral valve procedure (repair or replacement), body mass index, preoperative creatinine level, elective surgery status and STS risk score. Patients in the median sternotomy group were then matched on propensity score to patients in the minimally invasive group by using a caliper of 0.25 propensity score standard deviations. The sample remaining after PSM was n = 76 in each group, and the PSM procedure resulted in good covariate balance between the two groups ( Fig. 1) .
RESULTS

Patient characteristics
In this sample of patients who had undergone isolated mitral valve surgery, the mean age was 58 ± 13 years, 37% were female and the mean STS risk score was 2 ± 4% for mortality. The mean STS-predicted risk for morbidity/mortality was 13 ± 13%, and the STS-predicted risk for stroke/TIA was 1 ± 1%. Due to the selection process for patients who had minimally invasive surgery, patients who had median sternotomy were significantly older and had higher STS risk scores and more comorbidities ( Table 1 ). The PSM technique was employed to balance patient characteristics between the groups so that comparable groups of patients could be examined within each operative approach. The logistic model used to create the propensity score identified the following independent factors as predictors for minimally invasive operative approach: younger age [odds ratio (OR) = 0.96, P = 0.01], male sex (OR = 1.87, P = 0.04), mitral valve repair (OR = 8.56, P < 0.001), lower body mass index (OR = 0.95, P = 0.048) and elective status (OR = 33.63, P = 0.002). After PSM, patients in both groups had similar preoperative and surgical characteristics ( Table 2 ). In particular, after PSM, age (60 vs 63 years, P = 0.45) and STS risk scores for mortality (2 vs 1%, P = 0.27) and stroke (1 vs 1%, P = 0.41) were comparable in the median sternotomy and minimally invasive groups. The prevalence of preoperative comorbidities also became balanced after PSM.
Full-sample analyses
Before matching, the minimally invasive and median sternotomy groups did not differ in incidence of stroke/TIA (0.4 vs 1.4%, P = 0.56), although the minimally invasive group had a lower incidence of other major morbidity (0.8 vs 6.1%, P = 0.004) and operative mortality (0 vs 2.7%, P = 0.02) ( Table 3) . Even though the median sternotomy group had a significantly higher incidence of operative mortality, the observed cases were still less than predicted by the STS risk score [observed-to-expected (O/E) ratio = 0.84].
After adjustment for age and STS-predicted risk for stroke, there was no effect of operative approach on odds for stroke/TIA in the full sample [OR = 0.41, 95% confidence interval (CI) = 0.03-5.34, P = 0.49]. Similarly, after adjusting for age and STS-predicted risk for morbidity/mortality, there was no effect of operative approach on odds for other major morbidity (OR = 0.40, 95% CI = 0.07-2.34, P = 0.31).
Propensity score matching analyses
After PSM, the operative risk and comorbidities in the two groups were no longer different, and outcome analyses of comparable groups of patients were now possible. No patients in either PSM group experienced a permanent stroke/TIA, and major morbidity (1.3 vs 1.3%, P > 0.99) and operative mortality (0 vs 1.3%, P > 0.99) no longer differed between the minimally invasive and the median sternotomy groups.
DISCUSSION
In the present analysis, the use of a minimally invasive approach for mitral valve surgery performed on a fibrillating heart was not associated with a greater incidence of stroke/TIA or other major morbidity when compared with a median sternotomy procedure. We compared our minimally invasive approach for isolated mitral valve surgery and fibrillatory arrest with our experience with median sternotomy. Our collective experience includes more than 450 patients in which minimally invasive techniques have been used for various types of procedures (isolated mitral valve surgeries, mitral valve procedures combined with a Cox-Maze procedure and stand-alone Cox-Maze procedures), with only one perioperative stroke and two TIAs. Our practice of minimally invasive approaches with femoral cannulation and retrograde perfusion is performed only in cases where CT angiography findings demonstrate no evidence for significant vascular disease before the procedure. In cases of significant vascular pathology, median sternotomy or alternative access, such as axillary artery cannulation, should be considered to allow antegrade flow and minimize the risk of stroke. For this reason, patients with significant peripheral vascular disease were excluded from a minimally invasive fibrillating-heart operative approach.
The incidence of major morbidity was lower in patients who had minimally invasive procedures. After adjustment for age and STS risk, operative approach had no effect on the odds for stroke/ TIA and other major morbidity. PSM was then performed in the two patient groups and resulted in comparable preoperative characteristics. After PSM, no patient in either group experienced permanent stroke/TIA, and no differences were found in the incidence of other major morbidity in the two groups.
In the immediate wake of the development of minimally invasive techniques for mitral valve surgery, some published reports expressed concern that the results of these approaches were inferior to those of median sternotomy, particularly with regard to stroke and other complications [11] [12] [13] . Since their initial development, minimally invasive techniques have consistently been shown to yield improved outcomes, including decreases in bleeding and blood product transfusion, wound infection, ventilation time, length of stay and time to return to normal activity [4, 6, 14, 15] . Recent publications have demonstrated the safety and effectiveness of minimally invasive mitral surgery with a fibrillatory arrest method [16, 17] . Even in very experienced centres, however, minimally invasive mitral valve surgery and retrograde perfusion have been found to be associated with an increased risk for stroke [9] . In this study, we were not attempting to dismiss the important data coming from programmes with extensive experience in minimally invasive mitral valve surgery, but rather to highlight the importance of patient screening and selection. Screening patients for significant vascular disease will further improve our ability to select patients and achieve excellent outcomes. Our own experience with this technique demonstrated that median sternotomy and an alternative cannulation site are safer options in patients with vascular disease [10] .
We are aware of potential criticism that the information regarding the combination of retrograde perfusion and fibrillatory arrest is limited. In the past few years, we have accumulated experience with more than 450 patients that demonstrates the safety and effectiveness of this technique, as has been shown by others [10, 16] . The growing trend in the preference of minimally invasive approaches by both patients and referring physicians, together with the growing body of evidence for the safety and efficacy of such techniques, has led major centres to prefer minimally invasive techniques over median sternotomy procedures for mitral valve surgery.
In most centres, a fibrillating-heart approach is chosen only in redo cases. Thus, higher reported rates of neurological events in other series might also be applicable to redo cases, which may be associated with a higher stroke rate. Although our study was designed to evaluate only first-time cases, minimally invasive redo surgery at our centre (n = 30) resulted in a 0% incidence of stroke/TIA.
Finally, it is possible that minimally invasive mitral valve surgery without aortic cross-clamping and with fibrillary arrest might produce stroke rates similar to those seen with minimally invasive mitral valve surgery with aortic cross-clamping and cardioplegia. This question can be adequately answered only in a prospective randomized study.
Limitations
A limitation of this study is the fact that, as mentioned previously, all patients presenting with significant peripheral vascular disease on CT screening were excluded, according to our screening protocol for minimally invasive surgery. Although this protocol makes sense from a clinical standpoint, from a scientific perspective this selection process has the potential to generate bias. Our conclusions, therefore, are valid only for patients without relevant peripheral vascular disease on CT.
This study included a relatively small series representing the experience of a single centre and was not a prospective randomized trial, in which causality rather than association can be tested. Even though the PSM technique balanced the groups in a way that simulates randomization, unmeasured factors could still confound these results. In addition, the number of events at our centre is low, which reduces power and highlights the need for future studies addressing this issue with much larger sample sizes.
CONCLUSION
A minimally invasive operative approach for mitral valve surgery performed on a fibrillating heart with femoral cannulation was not associated with a greater incidence of stroke/TIA compared with a standard median sternotomy approach. When performed in a highly experienced centre, a minimally invasive approach with fibrillatory arrest did not increase the risk of perioperative stroke.
